223 related articles for article (PubMed ID: 19388153)
21. Elevation of Twist expression by arecoline contributes to the pathogenesis of oral submucous fibrosis.
Lee YH; Yang LC; Hu FW; Peng CY; Yu CH; Yu CC
J Formos Med Assoc; 2016 May; 115(5):311-7. PubMed ID: 26088962
[TBL] [Abstract][Full Text] [Related]
22. Arecoline-induced myofibroblast transdifferentiation from human buccal mucosal fibroblasts is mediated by ZEB1.
Chang YC; Tsai CH; Lai YL; Yu CC; Chi WY; Li JJ; Chang WW
J Cell Mol Med; 2014 Apr; 18(4):698-708. PubMed ID: 24400868
[TBL] [Abstract][Full Text] [Related]
23. Effects of arecoline, safrole, and nicotine on collagen phagocytosis by human buccal mucosal fibroblasts as a possible mechanism for oral submucous fibrosis in Taiwan.
Shieh DH; Chiang LC; Lee CH; Yang YH; Shieh TY
J Oral Pathol Med; 2004 Oct; 33(9):581-7. PubMed ID: 15357680
[TBL] [Abstract][Full Text] [Related]
24. β-catenin expression in areca quid chewing-associated oral squamous cell carcinomas and upregulated by arecoline in human oral epithelial cells.
Lee SS; Tsai CH; Tsai LL; Chou MC; Chou MY; Chang YC
J Formos Med Assoc; 2012 Apr; 111(4):194-200. PubMed ID: 22526207
[TBL] [Abstract][Full Text] [Related]
25. Synergistic effects of nicotine on arecoline-induced cytotoxicity in human buccal mucosal fibroblasts.
Chang YC; Hu CC; Tseng TH; Tai KW; Lii CK; Chou MY
J Oral Pathol Med; 2001 Sep; 30(8):458-64. PubMed ID: 11545236
[TBL] [Abstract][Full Text] [Related]
26. Arecoline stimulated early growth response-1 production in human buccal fibroblasts: suppression by epigallocatechin-3-gallate.
Hsieh YP; Chen HM; Chang JZ; Chiang CP; Deng YT; Kuo MY
Head Neck; 2015 Apr; 37(4):493-7. PubMed ID: 24436257
[TBL] [Abstract][Full Text] [Related]
27. Arecoline activates latent transforming growth factor β1 via mitochondrial reactive oxygen species in buccal fibroblasts: Suppression by epigallocatechin-3-gallate.
Hsieh YP; Wu KJ; Chen HM; Deng YT
J Formos Med Assoc; 2018 Jun; 117(6):527-534. PubMed ID: 28720506
[TBL] [Abstract][Full Text] [Related]
28. Arecoline-stimulated connective tissue growth factor production in human buccal mucosal fibroblasts: Modulation by curcumin.
Deng YT; Chen HM; Cheng SJ; Chiang CP; Kuo MY
Oral Oncol; 2009 Sep; 45(9):e99-e105. PubMed ID: 19457704
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of HIF1A-AS1 impedes the arecoline-induced migration activity of human oral mucosal fibroblasts.
Wang YK; Liu CM; Lin T; Fang CY; Yu CC; Yu CH
J Formos Med Assoc; 2020 Apr; 119(4):879-883. PubMed ID: 31959495
[TBL] [Abstract][Full Text] [Related]
30. Elevated expression of NF-kappaB in oral submucous fibrosis--evidence for NF-kappaB induction by safrole in human buccal mucosal fibroblasts.
Ni WF; Tsai CH; Yang SF; Chang YC
Oral Oncol; 2007 Jul; 43(6):557-62. PubMed ID: 16996785
[TBL] [Abstract][Full Text] [Related]
31. Increased plasminogen activator inhibitor-1/tissue type plasminogen activator ratio in oral submucous fibrosis.
Yang SF; Hsieh YS; Tsai CH; Chen YJ; Chang YC
Oral Dis; 2007 Mar; 13(2):234-8. PubMed ID: 17305628
[TBL] [Abstract][Full Text] [Related]
32. Deficiency in collagen and fibronectin phagocytosis by human buccal mucosa fibroblasts in vitro as a possible mechanism for oral submucous fibrosis.
Tsai CC; Ma RH; Shieh TY
J Oral Pathol Med; 1999 Feb; 28(2):59-63. PubMed ID: 9950251
[TBL] [Abstract][Full Text] [Related]
33. Areca nut-induced buccal mucosa fibroblast contraction and its signaling: a potential role in oral submucous fibrosis--a precancer condition.
Chang MC; Lin LD; Wu HL; Ho YS; Hsien HC; Wang TM; Jeng PY; Cheng RH; Hahn LJ; Jeng JH
Carcinogenesis; 2013 May; 34(5):1096-104. PubMed ID: 23349021
[TBL] [Abstract][Full Text] [Related]
34. Activation of TGF-β pathway by areca nut constituents: a possible cause of oral submucous fibrosis.
Khan I; Kumar N; Pant I; Narra S; Kondaiah P
PLoS One; 2012; 7(12):e51806. PubMed ID: 23284772
[TBL] [Abstract][Full Text] [Related]
35. Matrix metalloproteinase-1 expression in oral submucous fibrosis: an immunohistochemical study.
Mishra G; Ranganathan K
Indian J Dent Res; 2010; 21(3):320-5. PubMed ID: 20930336
[TBL] [Abstract][Full Text] [Related]
36. The upregulation of metallothionein-1 expression in areca quid chewing-associated oral squamous cell carcinomas.
Lee SS; Yang SF; Ho YC; Tsai CH; Chang YC
Oral Oncol; 2008 Feb; 44(2):180-6. PubMed ID: 17418620
[TBL] [Abstract][Full Text] [Related]
37. miR-200b ameliorates myofibroblast transdifferentiation in precancerous oral submucous fibrosis through targeting ZEB2.
Liao YW; Yu CC; Hsieh PL; Chang YC
J Cell Mol Med; 2018 Sep; 22(9):4130-4138. PubMed ID: 29893466
[TBL] [Abstract][Full Text] [Related]
38. E3 ligase carboxyl-terminus of Hsp70-interacting protein (CHIP) suppresses fibrotic properties in oral mucosa.
Chen SC; Liu CM; Hsieh PL; Liao YW; Lin YJ; Yu CC; Yu CH
J Formos Med Assoc; 2020 Feb; 119(2):595-600. PubMed ID: 31653576
[TBL] [Abstract][Full Text] [Related]
39. The expression of O(6) -methylguanine-DNA methyltransferase in human oral keratinocytes stimulated with arecoline.
Lee SS; Tsai CH; Yu CC; Ho YC; Hsu HI; Chang YC
J Oral Pathol Med; 2013 Sep; 42(8):600-5. PubMed ID: 23278137
[TBL] [Abstract][Full Text] [Related]
40. miR-200c inhibits the arecoline-associated myofibroblastic transdifferentiation in buccal mucosal fibroblasts.
Lu MY; Yu CC; Chen PY; Hsieh PL; Peng CY; Liao YW; Yu CH; Lin KH
J Formos Med Assoc; 2018 Sep; 117(9):791-797. PubMed ID: 29958727
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
